Latest News

Miami — Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on efficiently acquiring, developing and commercializing or monetizing promising therapeutic products and product candidates, announced financial results and recent corporate highlights for the full-year ended December 31, 2022. Lindsay A. Rosenwald, M.D., Fortress’ Chairman, President and Chief...
Eureka! Vancouver scientists from the Ovarian Cancer Research (OvCaRe) Program at BC Cancer Agency and Vancouver Coastal Health Research Institute have discovered that there appears to be a single spelling mistake in the genetic code of granulosa cell tumours, a rare and often untreatable form of ovarian cancer. This means...
Chicago — The Foundation for Sarcoidosis Research (FSR) is proud to launch the Stand Up for Sarc Campaign this April as part of National Sarcoidosis Awareness Month. Sarcoidosis (pronounced SAR-COY-DOE-SIS) is considered a rare, inflammatory disease characterized by the formation of granulomas—tiny clumps of inflammatory cells—in one or more organs...
CHICAGO, Ill. — The Foundation for Sarcoidosis Research (FSR) is honored to host its inaugural in-person training of FSR-GSCA Volunteer Patient Leaders from around the United States at Cleveland Clinic, the FSR Global Sarcoidosis Clinic Alliance (FSR-GSCA) Founding Member. This inaugural in-person training of FSR-GSCA Volunteer Patient Leaders has been...
MISSOULA — The American Red Cross is facing a severe blood shortage, so they’re asking you to donate if you can. On Wednesday, a blood drive took place to honor a boy whose life was saved, thanks to generous blood donors. Troy Ross was just 3-years old when he was...
FRAMINGHAM — Before he reached puberty, Dick Wyman suffered about 20 broken bones. His daughter, Christine Wyman Rossi, fractured her femur while in her mother’s womb, followed by about 20 more fractures while in her childhood. Wyman’s grandson, Jack, broke two legs when only 4 weeks old. The Wyman family...
The 10th annual Rare Disease Genomics Symposium, hosted by the University of Alabama at Birmingham (UAB), will showcase the latest research into rare genetic diseases and focus on next-generation genetic testing and patient empowerment, the university announced. The free in-person and virtual symposium, set for Friday, brings together researchers, doctors, and...